↓ Skip to main content

A new entity for the negotiation of public procurement prices for patented medicines in Mexico

Overview of attention for article published in Bulletin of the World Health Organization, August 2012
Altmetric Badge

Mentioned by

policy
3 policy sources
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A new entity for the negotiation of public procurement prices for patented medicines in Mexico
Published in
Bulletin of the World Health Organization, August 2012
DOI 10.2471/blt.12.106633
Pubmed ID
Authors

Octavio Gómez-Dantés, Veronika J Wirtz, Michael R Reich, Paulina Terrazas, Maki Ortiz

Abstract

As countries expand health insurance coverage, their expenditures on medicines increase. To address this problem, WHO has recommended that every country draw up a list of essential medicines. Although most medicines on the list are generics, in many countries patented medicines represent a substantial portion of pharmaceutical expenditure.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 4%
Student > Bachelor 1 2%
Student > Doctoral Student 1 2%
Professor 1 2%
Researcher 1 2%
Other 0 0%
Unknown 51 89%
Readers by discipline Count As %
Economics, Econometrics and Finance 2 4%
Computer Science 1 2%
Psychology 1 2%
Medicine and Dentistry 1 2%
Unknown 52 91%